Alissa Keegan M.D.

Alissa Keegan MD, PhD serves as the Executive Medical Director at CRISPR Therapeutics. Previously, Alissa held positions at Amgen as Clinical Research Medical Director and Clinical Research Sr Medical Scientist. Alissa's academic background includes a postdoctoral researcher role and a clinical pathology residency at Brigham and Women's Hospital, as well as a Molecular Genetic Pathology Fellowship at Harvard Medical School. Alissa completed medical and doctoral degrees at the University of California, Los Angeles, earning an M.D. in Microbiology and a Ph.D. in Chromatin Biology.